RECENT NEWS

Leica Biosystems continues to enhance digital pathology workflows with the US launch of the Aperio GT EliteTM scanner, along with Aperio iQC software incorporating unique rescan functionality.

Scientists have proven that a wildflower steeped in folklore for its medicinal powers has genuine healing qualities – and the potential to help combat antibiotic resistance.

Roche has announced the inauguration of the new research home in Basel, Switzerland, for the Institute of Human Biology (IHB).

Laboratory equipment manufacturer AnalytiChem has added new Redipor Legionella Agar Plates to its range of Redipor microbiological prepared media, offering a suite of ready-to-use, selective culture media options.

Leica Biosystems has announced a major expansion of the Aperio AI Store, reinforcing its momentum as a rapidly growing gateway to a curated menu of leading AI tools, seamlessly embedded in a single interface.

Health sectors around the world are continually improving diagnostic practices in hospital laboratories to provide clinicians with faster and more reliable information. One notable development has been the gradual transition from the traditional erythrocyte sedimentation rate (ESR) test to plasma viscosity (PV) as a preferred marker of inflammation.

The UK’s National Institute for Health and Care Research (NIHR) has launched a major new funding initiative, which will support high-quality randomised controlled trials (RCTs) for infectious diseases in Africa, South Asia and South-East Asia.

Euroimmun - part of Revvity - has installed a transformative diagnostics solution at the central immunology laboratory within the Black Country Pathology Services (BCPS) network, contributing to the managed service contract provided by Abbott Core Diagnostics.

Roche has announced that it has received CE Mark approval for its Elecsys Apolipoprotein E4 biomarker test – the first in vitro diagnostic (IVD) immunoassay to identify the presence of the ApoE4 gene variant in the bloodstream. The ApoE4 gene variant is associated with an increased risk of late-onset Alzheimer's disease and is present in approximately 40–60% of Alzheimer's patients.

The UK Health Security Agency (UKHSA) has recently provided specialist laboratory testing for a fridge-free tetanus and diphtheria vaccine that could help address the global challenges of distribution, storage, wastage, and CO₂ emissions associated with temperature-sensitive medicines.

Scientists at The Institute of Cancer Research, London, are supporting an international clinical trial of a promising new immunotherapy treatment for advanced ovarian cancer.

Health technology firm Royal Philips has expanded its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organisations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows.

German biotech company MODAG has announced the market launch of PD DETECT, the first CE-certified test kit for Parkinson’s disease.

Registration for the British Society For Microbial Technology’s 41st Annual Microbiology Conference is open now, with 'early-bird' prices available until 20 April. The event takes place on Thursday 21 May, at North London’s RAF Museum, Hendon.

Leica Biosystems has launched its breakthrough AI-Powered Karyotyping functionality on the CytoInsight GSL platform, marking a major technological advancement for cytogenetics laboratories seeking faster turnaround times, greater automation, and elevated consistency in chromosome analysis.

The Global Virus Network (GVN) marked the opening of its International Headquarters on 5 March at the University of South Florida (USF) Institute for Translational Virology and Innovation (ITVI), a GVN Center of Excellence.

An antibody test for the infectious disease Mpox was successfully developed during the new clade 1b outbreak in Rwanda, the first time that an assay of its kind has been validated within this setting.

The House of Lords Science and Technology Committee has launched an inquiry into innovation in the NHS, with a focus on personalised medicine and AI.

New analysis shows Clinical Practice Research Datalink has supported groundbreaking medical research across 29 countries with close to 3,800 published studies

Agilent Technologies has announced it has entered into a definitive agreement to acquire Biocare Medical, a global leader in clinical pathology, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $950 million.